MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Omega Protein Company Profile (NYSE:OME)

Consensus Ratings for Omega Protein (NYSE:OME) (?)
Ratings Breakdown: 2 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.60)
Consensus Price Target: $22.00 (10.06% upside)

Analysts' Ratings History for Omega Protein (NYSE:OME)
Show:
DateFirmActionRatingPrice TargetActions
4/28/2016WunderlichInitiated CoverageBuy$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/20/2016Pivotal ResearchUpgradeHold -> Buy$19.00 -> $23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/14/2015DA DavidsonDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/20/2015BB&T Corp.Reiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/11/2015Imperial CapitalUpgradeIn-Line -> Outperform$16.00 -> $19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/1/2014 forward)
Earnings History for Omega Protein (NYSE:OME)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/3/2016        
5/4/2016Q116$0.36$0.40$84.74 million$84.84 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/9/2016Q415$0.48$0.29$101.83 million$82.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2015Q315$0.35$0.66$100.59 million$112.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2015Q215$0.24$0.43$84.99 million$93.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/11/2015Q115$0.15$0.12$74.30 million$71.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/11/2015Q414$0.17$0.35$83.30 million$102.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/17/2014Q314$0.30$0.08$70.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2014$0.25$0.42ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/10/2014Q312$0.32$0.66$69.47 million$66.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2013Q2 2013$0.14$0.19$50.93 million$41.77 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Omega Protein (NYSE:OME)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.26$0.40$0.33
Q2 20162$0.45$0.54$0.50
Q3 20163$0.39$0.53$0.44
Q4 20162$0.14$0.41$0.28
Q1 20171$0.38$0.38$0.38
Q2 20171$0.42$0.42$0.42
Q3 20171$0.57$0.57$0.57
Q4 20171$0.43$0.43$0.43
(Data provided by Zacks Investment Research)
Dividend History for Omega Protein (NYSE:OME)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Omega Protein (NYSE:OME)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
12/4/2015Andrew JohannesenCFOSell5,298$23.26$123,231.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2015Mark Edward GriffininsiderSell29,561$21.83$645,316.63View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/9/2015Mark Edward GriffininsiderSell20,439$21.60$441,482.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2015Andrew JohannesenCFOSell1,000$14.00$14,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/25/2015Gregory P ToupsVPSell1,115$13.95$15,554.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/24/2015David Andrew OwenDirectorSell8,929$13.77$122,952.33View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2015Gregory P ToupsVPSell2,000$13.46$26,920.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2015Gregory P ToupsVPSell4,000$13.10$52,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/17/2014Gregory P ToupsVPSell2,500$14.75$36,875.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2014Gregory P ToupsVPSell2,500$15.25$38,125.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2014Andrew JohannesenCFOSell3,000$15.02$45,060.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2014John D HeldVPSell64,825$15.09$978,209.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2014Mark Edward GriffinInsiderSell2,300$14.77$33,971.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/18/2014Andrew JohannesenCFOSell2,700$13.96$37,692.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/6/2014Gregory P ToupsVPSell2,500$14.75$36,875.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/6/2014Mark Edward GriffinInsiderSell9,492$14.74$139,912.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2014Montgomery DeihlInsiderSell4,000$14.59$58,360.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/29/2014Gregory P ToupsVPSell5,000$14.33$71,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/8/2014Gregory ToupsVPSell5,000$13.37$66,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2014William LandsDirectorSell10,000$11.85$118,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/17/2013William E M LandsDirectorSell10,000$10.61$106,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2013David Andrew OwenDirectorBuy1,333$10.31$13,743.23View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/1/2013David Andrew OwenDirectorBuy1,888$6.06$11,441.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2012David Andrew OwenDirectorBuy1,305$6.80$8,874.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Omega Protein (NYSE:OME)
DateHeadline
06/30/16 07:15 AMOmega Protein Corp. breached its 50 day moving average in a Bullish Manner : OME-US : June 30, 2016 -
06/29/16 08:29 AMOmega Protein shareholders elect activist investor's board nominees - Daily Mail
06/28/16 05:36 PMOmega Protein shareholders elect activist's board nominees
06/28/16 12:55 PMOmega Protein shareholders elect activist investor's board nominees -
06/28/16 10:56 AMWynnefield Capital's Full Slate Of Independent Nominees Resoundingly Elected To Board Of Omega Protein Corporation - [PR Newswire] - NEW YORK, June 28, 2016 /PRNewswire/ -- Wynnefield Capital and its affiliates (collectively, "Wynnefield"), longstanding stockholders of Omega Protein Corporation (NYSE: OME) ("Omega" ...
06/28/16 10:28 AMHigh-Quality Whey Protein (in the Right Amounts) May Be Helpful for Weight Loss - ProHealth
06/27/16 08:10 AM5 Reasons Why You Should Invest in J.M. Smucker (SJM) Now -
06/24/16 05:34 PMGym-free fitness ideas anyone can do - Wausau Daily Herald
06/24/16 08:12 AMOmega Protein Corporation (NYSE:OME) Updated Price Targets - FTSE News
06/23/16 06:09 PMInflamed and stressed: Antioxidant solutions that repair and rejuvinate - NutraIngredients.com
06/23/16 08:19 AMHow blood biomarker analysis can help plan meals, boost performance - Sports Illustrated
06/21/16 05:10 PMDeclines in fish supply threaten developing countries, UAPB professor says - Pine Bluff Commercial
06/21/16 10:02 AMPea Milk Is Now a Thing That Exists - InStyle
06/20/16 05:28 PMReady-to-Use Next-Gen Tahini Launches at Fancy Food - PR Newswire (press release)
06/20/16 05:28 PMAre you tired and forgetful all the time? How to banish the brain fog - Mirror.co.uk
06/20/16 05:28 PM13 Nutrients To Consume For A Happier Outlook On Life, According To Experts - Bustle
06/20/16 07:15 AMTwo firms recommend voting against Omega board director - IntraFish.com
06/18/16 04:54 PMAquaculture feed industry needs 'profitable' Chile salmon sector, Biomar says - Undercurrent News
06/18/16 09:49 AMBRIEF-Omega Protein responds to reports from ISS and Glass Lewis relating to directors election - Reuters
06/17/16 05:26 PMOmega Protein Clarifies Critical Facts for Stockholders
06/17/16 08:24 AMElla Allred recommends how to eat right for your AGE - Daily Mail
06/17/16 08:24 AMFalling Fish Catches Could Mean Malnutrition in Developing World - Laboratory Equipment
06/17/16 08:24 AMProxy Advisor Glass Lewis Recommends That Omega Protein Stockholders Vote For Wynnefield Nominee Michael ... - PR Newswire (press release)
06/17/16 07:51 AMProxy Advisor Glass Lewis Recommends That Omega Protein Stockholders Vote For Wynnefield Nominee Michael Christodolou To Replace Incumbent Director Gary Ermers - [PR Newswire] - NEW YORK, June 17, 2016 /PRNewswire/ -- Wynnefield Capital and its affiliates (collectively, "Wynnefield"), longstanding stockholders of Omega Protein Corporation (OME) ("Omega" or the "Company") with a 7.9% ownership interest, today announced that Glass, Lewis & Co. ("Glass Lewis"), a leading independent proxy voting and corporate governance advisory firm, recommended that its clients vote FOR the election of Wynnefield independent nominees Michael N. Christodolou and David H. Clarke to Omega's Board of Directors, thereby replacing director Gary Ermers. Glass Lewis joins Institutional Shareholder Services in recommending their clients vote for Wynnefield's independent nominees.
06/16/16 06:51 AMISS backs activist directors for Omega Protein's board - [Reuters] - A shareholder advisory service has recommended that Omega Protein Corp. stock holders vote for two directors brought forward by an activist investor to serve on the company's board. Institutional Shareholder Services (ISS) threw its support behind Michael Christodolou and David Clarke, two board candidates that Wynnefield Capital has nominated in its proxy fight against the nutritional product company. ISS found Wynnefield's nominees are more likely to deliver changes needed at the company than the targeted incumbent board members, the New York hedge fund said in a press release.
06/16/16 06:00 AMInstitutional Shareholder Services Recommends That Omega Protein Stockholders Vote For Wynnefield Nominee Michael Christodolou To Replace Incumbent Director Gary Ermers - [PR Newswire] - NEW YORK, June 16, 2016 /PRNewswire/ -- Wynnefield Capital and its affiliates (collectively, "Wynnefield"), longstanding stockholders of Omega Protein Corporation (NYSE: OME) ("Omega" ...
06/14/16 04:18 PMNevada State Court Orders Omega Protein To Produce NOBO Shareholder List By 3PM PT On Thursday, June 16, 2016 - [PR Newswire] - NEW YORK, June 14, 2016 /PRNewswire/ -- Wynnefield Capital and its affiliates (collectively "Wynnefield"), longstanding stockholders of Omega Protein Corporation (NYSE: OME) ("Omega or the ...
06/14/16 02:59 PMOmega Protein Announces Court Denies Wynnefield's Motion For Preliminary Injunction - [at noodls] - HOUSTON, June 14, 2016 /PRNewswire/ -- Omega Protein Corporation (NYSE: OME), a nutritional product company and a leading integrated provider of specialty oils and specialty protein products, today issued ...
06/14/16 02:56 PMOMEGA PROTEIN CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
06/14/16 08:30 AMThe Zacks Analyst Blog Highlights: Dean Foods, Omega Protein, Tyson Foods and United Natural Foods -
06/13/16 08:35 AMWynnefield Capital : Issues Letter To Omega Protein Stockholders
06/13/16 07:45 AMWynnefield Capital Issues Letter To Omega Protein Stockholders - [PR Newswire] - "Michael Christodolou is an excellent potential director of OME – we've known Mike for 25 years and would concur that he would be terrific for OME," investment research report released on March 10, 2016 by Pivotal Research Group, a strong supporter of Omega Protein.
06/13/16 07:19 AMOmega Protein Details Important Facts For Stockholders - [at noodls] - HOUSTON, June 13, 2016 /PRNewswire/ -- The Board of Directors of Omega Protein Corporation (NYSE: OME) (the 'Company' or 'Omega Protein'), today released a letter to stockholders in connection with the ...
06/09/16 04:27 PMWynnefield Capital Comments On Recent Omega Protein Communications, Is Disappointed Over Release Of Private Communications - Wynnefield Capital and its affiliates (collectively, "Wynnefield"), longstanding stockholders of Omega Protein Corporation (NYSE: OME) ("Omega" or the "Company") with a 7.9% beneficial ownership interest, today commented on a package of recent communications released by Omega, including its investor presentation, dated June 7, 2016, and a letter sent to stockholders, dated June 8, 2016. Wynnefield believes that Omega's communications destroy their credibility and are clearly designed to mislead stockholders and divert them from the damaging facts about their Board's poor decisions, lack of qualifications and repeated governance failures. Nelson Obus, President of Wynnefield, said "In the last few days, Omega has released a series of communications that together reflect the Board's and management's misguided attempt to further entrench themselves by preventing the election of Michael Christodolou to Omega's Board, despite his superior qualifications compared to current director Gary Ermers. We are puzzled as to why Omega's Board is afraid of Mr. Christodolou's independent perspective, judgement and vast expertise. "Likewise, we are disappointed that the Board has resorted to releasing private communications from an impassioned stockholder, who is not even a nominee for the board. Omega should be focused on making the case for why Gary Ermers is better suited than Michael Christodolou. Omega's Board and its external advisors are more concerned with jumping in muddy puddles than correcting the strategic, operational and governance deficiencies that they have presided over. "The facts, however, speak for themselves…in the four calendar years (ending December 31, 2015), Omega's Board and management team have allocated approximately $168 million of capital towards a Human Nutrition segment, included therein is a $23.6 million loss from operations – diverting valuable resources and management's time from a high margin Animal Nutrition business that generated $235.4 million of operating income over the same time period. "The current Board not only presided over this strategic and operational failure but has taken numerous shareholder unfriendly actions to entrench themselves. This should come as no surprise to the investment community. This is the same Board that has historically been unresponsive to stockholders' concerns and has routinely put their interests before stockholders. This is also the same Board that has done everything it can to prevent Michael Christodolou from joining its ranks, beginning with refusing to meet or to even speak with a highly qualified nominee like Michael in the Fall of 2015, particularly when he had been simply suggested by one of the Company's largest and longest term stockholders to fill a vacancy that still remains to this day. "It is resoundingly clear to Wynnefield, and other concerned stockholders, that Omega's behavior is a last-ditch effort to obfuscate the fact that Mr. Ermers is not qualified to serve on Omega's Board and that Mr. Christodolou is a vastly superior nominee who would serve the best interests of the Company and protect stockholder value by installing a disciplined strategic and capital allocation mentality. While Wynnefield looks forward to directly engaging with stockholders, it believes it is prudent to point out at least some of the major distortions embedded in the Company's presentation. 1. Nominee Qualifications. On slide 28, Omega states that Michael Christodolou lacks any "relevant, additive skills" including Operational Risk Management Duties, Direct Finance and Audit Experience, M&A/Business Development. This is laughable, given the fact that Michael Christodolou: Has a combined 22 years of serving with distinction on several public company boards, including for 17 years as a director and 12 years as Chairman of Lindsay Corporation, an agricultural related company, as well as 21 years of aggregate service on public company audit committees. Intimately involved in the strategic planning, analysis, approval and board oversight of approximately one dozen acquisitions valued at approximately $200 million during his tenure with Lindsay. Has 30+ years of accomplishments as a professional investor collaborating with and assisting the management teams and boards of directors of public companies on corporate and financial strategies to enhance shareholder value, including acquisitions, divestitures, operational restructurings and optimized capital structures. On the other hand, Board incumbent Gary Ermers is a hospital executive with no relevant expertise, though he does have a prior personal relationship with Omega Board member David Owen, Chair of the Company's Governance Committee. Ermers and Owen are long-time friends and neighbors, having served simultaneously on the Barkley Wood Homeowners' Association in Nicholasville, Kentucky. Prior to being appointed to Omega's Board by Mr. Owen and others in 2014, Mr. Ermers had never served on a public company board. He will for the first time face Omega stockholders at this year's Annual Meeting. A comparison of the candidates qualifications speak for themselves and can be found in an Exhibit below. 2. Human Nutrition performance and facts are absent. On slide 10, Omega compares its Animal Nutrition and Human Nutrition revenue to consolidated gross profit and margin. However, it conveniently does not disclose how much of the gross profit/margin comes from each of the businesses because they don't want stockholders to know how little comes from Human Nutrition given the size of the business and how much money Omega squandered to develop it. There is no disputing that Human Nutrition gross margins (approximately 12%) are not as attractive as Animal Nutrition gross margins (nearly 37%). Omega makes no effort to justify spending $168 million on a business that has lost $23.6 million over the last four calendar years (ending December 31, 2015) nor does it provide an explanation as to why the Human Nutrition segment is worth a fraction of the $168 million committed – based on statements made by the Company's CEO on the last earnings call. 3. Cherry Picking Peer Group to Fabricate Performance. On slides 14-19, when discussing total shareholder return (TSR), Omega has once again skewed perspective and changed its peer group materially, altering ...Full story available on Benzinga.com
06/09/16 03:38 PM4:38 pm Omega Protein: Wynnefield Capital (7.9% stake) comment on a package of recent communications released by Omega -
06/09/16 03:35 PMWynnefield Capital Comments On Recent Omega Protein Communications - [PR Newswire] - NEW YORK, June 9, 2016 /PRNewswire/ -- Wynnefield Capital and its affiliates (collectively, "Wynnefield"), longstanding stockholders of Omega Protein Corporation (NYSE: OME) ("Omega" ...
06/09/16 07:29 AMOmega Protein to Present at the Oppenheimer 16th Annual Consumer Conference - [at noodls] - HOUSTON, June 9, 2016 /PRNewswire/ -- Omega Protein Corporation (NYSE: OME), a nutritional product company and a leading integrated provider of specialty oils and specialty protein products, today announced ...
06/08/16 07:18 AMOmega Protein Sends Letter To Stockholders - [at noodls] - HOUSTON, June 8, 2016 /PRNewswire/ -- The Board of Directors of Omega Protein Corporation (NYSE: OME) (the 'Company' or 'Omega Protein'), today issued a letter to stockholders in connection with the Company's ...
06/06/16 09:18 AMKekst, AbMac in Omega Proxy Showdown
06/06/16 09:18 AMWynnefield Capital Compelled to Sue Omega Protein For Failure to Make Available Full Set of Books and Records
06/05/16 07:18 AMOmega Protein Issues Statement in Response to Frivolous Litigation Tactic by Wynnefield Capital - [at noodls] - HOUSTON, June 5, 2016 /PRNewswire/ -- Omega Protein Corporation (NYSE: OME), a nutritional product company and a leading integrated provider of specialty oils and specialty protein products, today issued ...
06/03/16 06:05 PMPlant-Based Protein Market : Share, Forecast and Demand 2016 - 2022
06/02/16 06:00 PMThe 5 foods you need to eat for super-shiny, healthy hair - Well+Good - Well+GoodThe 5 foods you need to eat for super-shiny, healthy hairWell+GoodChia seeds not only supply great whole-beauty fat, but also omega-3 fatty acids that promote circulation, ensuring that maximum nutrition gets to your hair follicle. ... It contains a whole host of minerals, antioxidants, and B vitamins, and is a ...
06/02/16 06:00 PMRevealed, the 10 best foods to eat for clear skin - Daily Mail - Daily MailRevealed, the 10 best foods to eat for clear skinDaily MailOmega 3 and 6 fatty acids from oily fish help skin to be healthier and less inflamed. ... Selenium is an antioxidant mineral that helps protect the skin from inflammation and sun damage and preserves elastin, a protein that keeps the skin smooth and tight.and more »
06/02/16 08:36 AMRecent research: Plant-based protein market outlook from 2016 to 2022 - WhaTech - Recent research: Plant-based protein market outlook from 2016 to 2022WhaTech... Midland Company, Cargill, Incorporated, E. I. du Pont de Nemours and Company, Fonterra Co-Operative Group, Kerry Group plc , Beyond Meat, Sun Brothers, LLC., Vega, AMCO Proteins, Hilmar Cheese Company, Inc., and Omega Protein Corporation.
06/01/16 08:33 AMIt's World Milk Day today but what are the REAL benefits of the white stuff? - Express.co.uk - Express.co.ukIt's World Milk Day today but what are the REAL benefits of the white stuff?Express.co.ukThe calories in milk come from three sources – carbohydrate, protein and fat – but people can reduce their calorie intake by selecting a skimmed or semi-skimmed drink. The exact number of calories in milk can vary between brands, but diabetes.co.uk ...and more »
06/01/16 08:33 AMTraders Are Bullish Omega Protein Corporation After The Stock Formed Bullish Double Top Pattern - HNN - Traders Are Bullish Omega Protein Corporation After The Stock Formed Bullish Double Top PatternHNNThe chart of Omega Protein Corporation (OME) shows a double top with $52.71 target or 167.00% above today's $19.74 share price. The 5 months chart pattern indicates low risk for the $438.59 million company. It was reported on Jun, 1 by Finviz.com.and more »
05/31/16 05:53 PM10 Vegan fitness food staples by Pola Pospieszalska Vegan Personal Trainer and Food Coach - FemaleFirst.co.uk - FemaleFirst.co.uk10 Vegan fitness food staples by Pola Pospieszalska Vegan Personal Trainer and Food CoachFemaleFirst.co.ukMany of my clients who have become interested in the increasingly popular vegan lifestyle, worry how to efficiently replace animal protein with plants without losing the gains or energy needed for performance. The good news is that eating a well ...
05/31/16 08:09 AMGlobal Protein Ingredient Industry - PR Newswire (press release) - Global Protein Ingredient IndustryPR Newswire (press release)Table 28: Leading Players in the Global Functional Drinks Market (2013): Percentage Share Breakdown of Value Sales by Coca-Cola Co., PepsiCo Inc., Red Bull GmbH, and Others (includes corresponding Graph/Chart) II-32 Functional Dairy Products: Most ...and more »
05/31/16 07:48 AMWynnefield Capital Files Definitive Proxy Statement For Omega Protein Annual Meeting - [PR Newswire] - NEW YORK, May 31, 2016 /PRNewswire/ -- Wynnefield Capital and its affiliates (collectively, "Wynnefield"), longstanding stockholders of Omega Protein Corporation (OME) ("Omega" or the "Company") with a 7.9% ownership interest, announced the filing of definitive proxy materials with the Securities and Exchange Commission ("SEC") to elect Michael N. Christodolou and David H. Clarke to the Company's Board. The Company's annual meeting is scheduled for June 28, 2016. Despite Wynnefield's good faith attempts at settlement, Omega's Board and management team consistently delayed and later unilaterally terminated all discussions, which might have avoided a proxy contest that it has acknowledged will be expensive and distracting.
About Omega Protein

Omega Protein logoOmega Protein Corporation is a nutritional product company. The Company operates through two segments: animal nutrition and human nutrition. The animal nutrition segment consists primarily of two subsidiaries: Omega Protein, Inc. (Omega Protein) and Omega Shipyard, Inc. (Omega Shipyard). Omega Protein, the principal operating subsidiary, produces animal nutrition products and operates in the menhaden harvesting and processing business. Omega Shipyard owns and operates a 49.4 acre shipyard facility in Moss Point, Mississippi. The human nutrition segment has three primary product lines: dairy protein products, specialty oils and fatty acids, and other nutraceutical ingredients. The human nutrition business consists of Nutegrity, a division of the Company, consisting of three subsidiaries: Cyvex Nutrition, Inc. (Cyvex), InCon Processing, L.L.C. (InCon) and Wisconsin Specialty Protein, L.L.C. (WSP), and Bioriginal Food & Science Corp. (Bioriginal).

Industry, Sector and Symbol:
  • Sector: Consumer Goods
  • Industry: Processed & Packaged Goods
  • Sub-Industry: Packaged Foods & Meats
  • Exchange: NYSE
  • Symbol: OME
  • CUSIP: 68210P10
Key Metrics:
  • Previous Close: $19.99
  • 50 Day Moving Average: $19.32
  • 200 Day Moving Average: $19.78
  • P/E Ratio: 14.73
  • P/E Growth: 1.39
  • Market Cap: $444.82M
  • Current Quarter EPS Consensus Estimate: $1.71 EPS
Additional Links:
Omega Protein (NYSE:OME) Chart for Friday, July, 1, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha